Covid-19 Research | Quanterix

The ability to differentiate elevated cytokine and chemokine levels, such as IL-6, IL-1b, IL-10, IL-8, and TNFα, from healthy baseline with the highest level of precision is critical to SARS-Cov-2 research. The Simoa SP-X Imaging and Analysis System is accelerating research efforts with the cost-effective solution for monitoring these targets with sensitivity and precision!

Now available on our HD-X platform, we are proud to introduce the ultra-sensitive Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody assay. Our assay targets antibodies directed against the viral spike protein and provides a numerical result representing the concentration of antibodies from 0.21 to 250 mg/mL. Learn more about its application by downloading the recently published app note.

Download the App Note

Learn More About the Antibody Test

First Name(Required)

Last Name(Required)

Email(Required)

Company(Required)

Organization Type(Required)

Country(Required)

State

Postal Code(Required)

Phone

What therapeutic area(s) are of interest?

What disease(s) are you focused on?

Additional Comments

I would like to receive emails about Quanterix’s products and services.

Send Message

By submitting the form you agree to Quanterix’s Terms and Conditions. If you have subscribed to our email marketing you can unsubscribe at any time, and you can learn more about how we manage your personal details in our Privacy Policy.

Th1/Th2 customizable panel with up to 10 critical markers for cytokine profiling and COVID-19 induced cytokine storm

Plasma & Serum	IFNy	IL-1β	IL-4	IL-5	IL-6	IL-8	IL-10	IL-12p70	IL-22	TNFα
LLOD %	80%	85%	43%	100%	100%	100%	100%	58%	100%	100%
LLOQ %	68%	28%	30%	68%	100%	98%	100%	13%	100%	100%

Chemokine panel for cytokine storm

Above LLOQ %	IP-10	ITAC	MCP-1	MIP-3b
Plasma	100%	100%	58%	100%
Serum	100%	68%	13%	100%

Angiogenesis panel monitoring and predicting vascular disease associated with COVID-19

Above LLOQ %	ANG-2	HB-EGF	VEGF-C	PlGF	FGFb	HGF	VEGF
Plasma	100%	100%	83%	100%	0%	92%	100%
Serum	100%	100%	100%	100%	0%	92%	100%

Speak to a Sales Rep View COVID-19 Webinar

Does your research focus on neuropathy associated with SARS-Cov-2 infection?

Simoa® Full Assay Menu

Simoa® for Cytokine Profiling and Antibody Detection in COVID-19 Research

Request More Information

Th1/Th2 customizable panel with up to 10 critical markers for cytokine profiling and COVID-19 induced cytokine storm

Chemokine panel for cytokine storm

Angiogenesis panel monitoring and predicting vascular disease associated with COVID-19

Does your research focus on neuropathy associated with SARS-Cov-2 infection?

Aging
ALS
Alzheimer’s Disease
Angiogenesis
Bioprocess
Brain Cancer
Breast Cancer
Carcinoma
Colorectal cancer
COVID-19
Cytokines
Dementia
Diabetes
FTD
Head/ Neck Cancer
Heart Disease
Hepatitis
HIV
Huntington’s Disease
Immuno-oncology
Infectious Disease
Leukemia
Liver Cancer
Lung cancer
Lupus
Lymphoma
Malaria
Mental Health
Multiple Sclerosis
Obesity
Ovarian Cancer
Pain
Pancreatic cancer
Parkinson’s
Prenatal
Prostate Cancer
PTSD
Rheumatoid
Sarcoma Cancer
Skin cancer
Stroke
TBI
Thyroid
Trauma
Tuberculosis
Women's Health

Simoa® for Cytokine Profiling and Antibody Detection in COVID-19 Research

Request More Information

Th1/Th2 customizable panel with up to 10 critical markers for cytokine profiling and COVID-19 induced cytokine storm

Chemokine panel for cytokine storm

Angiogenesis panel monitoring and predicting vascular disease associated with COVID-19

COVID-19 Research Assay Menu

CORPLEX™ CYTOKINE PANEL (IFN-γ, IL-1β, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12P70, IL-22, TNFα)

G-CSF

IL-15

IL-17A

IL-7 Assays

Interferon-alpha (IFN-α) Assay

PD-L1

SARS-CoV-2 N PROTEIN ANTIGEN (RUO)

SARS-CoV-2 SPIKE IGG (RUO)

Does your research focus on neuropathy associated with SARS-Cov-2 infection?